MVM
Medicxi Ventures Management Portfolio holdings
AUM
$427M
This Quarter Return
-13.55%
1 Year Return
+42.94%
3 Year Return
+262.94%
5 Year Return
+109.92%
10 Year Return
–
AUM
$400M
AUM Growth
+$400M
(-13%)
Cap. Flow
+$53.9M
Cap. Flow
% of AUM
13.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Aura Biosciences
AURA
|
$51.6M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$2.25M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.25B
| $204M | 51.07% | 18,123,892 +200,000 | +1% | +$2.25M |
|
|
2
Aura Biosciences
AURA
$389M
| $51.6M | 12.92% | +3,039,892 | New | +$51.6M |
|
3
Merus
MRUS
$4.98B
| $50.9M | 12.73% | 1,600,000 | – | – |
|
4
Vaxcyte
PCVX
$4B
| $44.9M | 11.24% | 1,887,478 | – | – |
|
5
Phathom Pharmaceuticals
PHAT
$864M
| $40.7M | 10.18% | 2,067,861 | – | – |
|
|
CMPI
6
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $4.31M | 1.08% | 1,501,716 | – | – |
|
|
OBSV
7
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $3.12M | 0.78% | 1,570,000 | – | – |
|